Do analysts recommend PHG or MMED?

MiniMed Group has a consensus target price of $23.77, indicating a potential upside of 8.19%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts plainly believe MiniMed Group is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 MiniMed Group 1 Sell rating(s) 2 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.75

Does the media prefer PHG or MMED?

In the previous week, MiniMed Group had 2 more articles in the media than Koninklijke Philips. MarketBeat recorded 4 mentions for MiniMed Group and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat MiniMed Group's score of 1.10 indicating that Koninklijke Philips is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, STE or MMED?

STERIS has higher revenue and earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio STERIS $6.04B 3.45 $782.30M $8.18 26.09 MiniMed Group $3.22B 1.92 -$333M -$0.68 N/A

Does the media refer more to STE or MMED?

In the previous week, STERIS and STERIS both had 4 articles in the media. STERIS's average media sentiment score of 1.41 beat MiniMed Group's score of 1.10 indicating that STERIS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STERIS 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ZBH or MMED?

In the previous week, Zimmer Biomet had 9 more articles in the media than MiniMed Group. MarketBeat recorded 13 mentions for Zimmer Biomet and 4 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 1.10 beat Zimmer Biomet's score of 0.72 indicating that MiniMed Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 6 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MMED or BAX?

In the previous week, Baxter International had 17 more articles in the media than MiniMed Group. MarketBeat recorded 21 mentions for Baxter International and 4 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 1.10 beat Baxter International's score of 1.02 indicating that MiniMed Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 7 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MMED or PEN?

In the previous week, Penumbra had 3 more articles in the media than MiniMed Group. MarketBeat recorded 7 mentions for Penumbra and 4 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 1.10 beat Penumbra's score of 1.09 indicating that MiniMed Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

MiniMed Group (MMED) Competitors

$21.97 -0.53 (-2.36%)

Closing price 09/14/2026 04:00 PM Eastern

Extended Trading

$22.15 +0.18 (+0.81%)

As of 05:41 AM Eastern

Compare

MMED vs. PHG, STE, ZBH, BAX, and PEN

Should you buy MiniMed Group stock or one of its competitors? MiniMed Group's main competitors and comparable companies include Koninklijke Philips (PHG), STERIS (STE), Zimmer Biomet (ZBH), Baxter International (BAX), and Penumbra (PEN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does MiniMed Group compare to Koninklijke Philips?

Koninklijke Philips (NYSE:PHG) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Koninklijke Philips has a net margin of 6.30% compared to MiniMed Group's net margin of 0.00%. Koninklijke Philips' return on equity of 14.38% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	6.30%	14.38%	5.96%
MiniMed Group	N/A	N/A	N/A

13.7% of Koninklijke Philips shares are owned by institutional investors. 0.0% of MiniMed Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Koninklijke Philips has higher revenue and earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.22	$1.01B	$1.36	18.44
MiniMed Group	$3.22B	1.92	-$333M	-$0.68	N/A

MiniMed Group has a consensus target price of $23.77, indicating a potential upside of 8.19%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts plainly believe MiniMed Group is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, MiniMed Group had 2 more articles in the media than Koninklijke Philips. MarketBeat recorded 4 mentions for MiniMed Group and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat MiniMed Group's score of 1.10 indicating that Koninklijke Philips is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Koninklijke Philips beats MiniMed Group on 9 of the 15 factors compared between the two stocks.

How does MiniMed Group compare to STERIS?

STERIS (NYSE:STE) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

94.7% of STERIS shares are owned by institutional investors. 1.1% of STERIS shares are owned by insiders. Comparatively, 0.0% of MiniMed Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

STERIS has a net margin of 13.34% compared to MiniMed Group's net margin of 0.00%. STERIS's return on equity of 14.34% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STERIS	13.34%	14.34%	9.66%
MiniMed Group	N/A	N/A	N/A

STERIS currently has a consensus price target of $271.33, indicating a potential upside of 27.15%. MiniMed Group has a consensus price target of $23.77, indicating a potential upside of 8.19%. Given STERIS's higher possible upside, research analysts plainly believe STERIS is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STERIS	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

STERIS has higher revenue and earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STERIS	$6.04B	3.45	$782.30M	$8.18	26.09
MiniMed Group	$3.22B	1.92	-$333M	-$0.68	N/A

In the previous week, STERIS and STERIS both had 4 articles in the media. STERIS's average media sentiment score of 1.41 beat MiniMed Group's score of 1.10 indicating that STERIS is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STERIS	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

STERIS beats MiniMed Group on 12 of the 13 factors compared between the two stocks.

How does MiniMed Group compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings.

88.9% of Zimmer Biomet shares are held by institutional investors. 1.3% of Zimmer Biomet shares are held by company insiders. Comparatively, 0.0% of MiniMed Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Zimmer Biomet has a net margin of 9.48% compared to MiniMed Group's net margin of 0.00%. Zimmer Biomet's return on equity of 13.12% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	9.48%	13.12%	7.23%
MiniMed Group	N/A	N/A	N/A

Zimmer Biomet currently has a consensus price target of $104.42, suggesting a potential upside of 8.04%. MiniMed Group has a consensus price target of $23.77, suggesting a potential upside of 8.19%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts plainly believe MiniMed Group is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	2 Sell rating(s)	14 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.26
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

Zimmer Biomet has higher revenue and earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$8.23B	2.24	$705.20M	$4.11	23.52
MiniMed Group	$3.22B	1.92	-$333M	-$0.68	N/A

In the previous week, Zimmer Biomet had 9 more articles in the media than MiniMed Group. MarketBeat recorded 13 mentions for Zimmer Biomet and 4 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 1.10 beat Zimmer Biomet's score of 0.72 indicating that MiniMed Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	6 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Zimmer Biomet beats MiniMed Group on 12 of the 16 factors compared between the two stocks.

How does MiniMed Group compare to Baxter International?

MiniMed Group (NASDAQ:MMED) and Baxter International (NYSE:BAX) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

MiniMed Group has higher earnings, but lower revenue than Baxter International. MiniMed Group is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.22B	1.92	-$333M	-$0.68	N/A
Baxter International	$11.24B	1.10	-$957M	-$2.07	N/A

In the previous week, Baxter International had 17 more articles in the media than MiniMed Group. MarketBeat recorded 21 mentions for Baxter International and 4 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 1.10 beat Baxter International's score of 1.02 indicating that MiniMed Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	7 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MiniMed Group has a net margin of 0.00% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Baxter International	-9.27%	16.57%	5.24%

MiniMed Group presently has a consensus price target of $23.77, indicating a potential upside of 8.19%. Baxter International has a consensus price target of $22.45, indicating a potential downside of 5.80%. Given MiniMed Group's stronger consensus rating and higher probable upside, research analysts plainly believe MiniMed Group is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

90.2% of Baxter International shares are owned by institutional investors. 0.0% of MiniMed Group shares are owned by insiders. Comparatively, 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

MiniMed Group beats Baxter International on 8 of the 15 factors compared between the two stocks.

How does MiniMed Group compare to Penumbra?

MiniMed Group (NASDAQ:MMED) and Penumbra (NYSE:PEN) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment.

Penumbra has a net margin of 10.67% compared to MiniMed Group's net margin of 0.00%. Penumbra's return on equity of 10.50% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Penumbra	10.67%	10.50%	8.17%

MiniMed Group currently has a consensus price target of $23.77, indicating a potential upside of 8.19%. Penumbra has a consensus price target of $367.07, indicating a potential upside of 14.70%. Given Penumbra's higher probable upside, analysts plainly believe Penumbra is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

In the previous week, Penumbra had 3 more articles in the media than MiniMed Group. MarketBeat recorded 7 mentions for Penumbra and 4 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 1.10 beat Penumbra's score of 1.09 indicating that MiniMed Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

88.9% of Penumbra shares are held by institutional investors. 0.0% of MiniMed Group shares are held by insiders. Comparatively, 2.9% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Penumbra has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.22B	1.92	-$333M	-$0.68	N/A
Penumbra	$1.40B	8.98	$177.69M	$4.07	78.63

Summary

Penumbra beats MiniMed Group on 11 of the 15 factors compared between the two stocks.

Get MiniMed Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MMED vs. The Competition

Export

Metric	MiniMed Group	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$6.33B	$5.42B	$7.16B	$14.30B
Dividend Yield	N/A	1.80%	2.57%	11.71%
P/E Ratio	-32.31	25.11	273.30	25.37
Price / Sales	1.92	71.75	647.39	87.55
Price / Cash	N/A	33.03	28.42	34.96
Price / Book	1.71	6.03	10.48	6.24
Net Income	-$333M	$150.14M	$3.49B	$358.08M
7 Day Performance	-5.79%	-1.33%	-1.11%	-0.70%
1 Month Performance	9.03%	-3.22%	0.60%	-2.76%
1 Year Performance	N/A	9.62%	20.20%	6.72%

MiniMed Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MMED MiniMed Group	1.7026 of 5 stars	$21.97 -2.4%	$23.77 +8.2%	N/A	$6.33B	$3.22B	N/A	2,800	Gap Up High Trading Volume
PHG Koninklijke Philips	3.103 of 5 stars	$25.89 -0.6%	N/A	-11.1%	$25.45B	$17.67B	19.08	65,340	Positive News
STE STERIS	4.8109 of 5 stars	$224.60 -1.0%	$271.33 +20.8%	-14.7%	$21.90B	$6.04B	27.46	17,937	Positive News
ZBH Zimmer Biomet	3.7113 of 5 stars	$97.94 -1.0%	$104.42 +6.6%	-6.3%	$18.71B	$8.23B	23.83	17,000	Positive News
BAX Baxter International	1.4639 of 5 stars	$25.81 +0.9%	$22.45 -13.0%	-0.7%	$13.35B	$11.24B	N/A	37,500	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MMED) was last updated on 9/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MiniMed Group (MMED) Competitors

MMED vs. PHG, STE, ZBH, BAX, and PEN

How does MiniMed Group compare to Koninklijke Philips?

Summary

How does MiniMed Group compare to STERIS?

Summary

How does MiniMed Group compare to Zimmer Biomet?

Summary

How does MiniMed Group compare to Baxter International?

Summary

How does MiniMed Group compare to Penumbra?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MMED vs. The Competition

MiniMed Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MiniMed Group (MMED) Competitors

MMED vs. PHG, STE, ZBH, BAX, and PEN

How does MiniMed Group compare to Koninklijke Philips?

Is PHG or MMED more profitable?

Do institutionals and insiders believe in PHG or MMED?

Which has better valuation and earnings, PHG or MMED?

Do analysts recommend PHG or MMED?

Does the media prefer PHG or MMED?

Summary

How does MiniMed Group compare to STERIS?

Do institutionals & insiders hold more shares of STE or MMED?

Is STE or MMED more profitable?

Do analysts rate STE or MMED?

Which has better earnings and valuation, STE or MMED?

Does the media refer more to STE or MMED?

Summary

How does MiniMed Group compare to Zimmer Biomet?

Do institutionals and insiders have more ownership in ZBH or MMED?

Is ZBH or MMED more profitable?

Do analysts rate ZBH or MMED?

Which has preferable earnings and valuation, ZBH or MMED?

Does the media prefer ZBH or MMED?

Summary

How does MiniMed Group compare to Baxter International?

Which has preferable earnings & valuation, MMED or BAX?

Does the media prefer MMED or BAX?

Is MMED or BAX more profitable?

Do analysts recommend MMED or BAX?

Do insiders and institutionals believe in MMED or BAX?

Summary

How does MiniMed Group compare to Penumbra?

Is MMED or PEN more profitable?

Do analysts recommend MMED or PEN?

Does the media prefer MMED or PEN?

Do institutionals and insiders hold more shares of MMED or PEN?

Which has better earnings & valuation, MMED or PEN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MMED vs. The Competition

MiniMed Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools